The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19
▻https://www.who.int/news-room/commentaries/detail/the-use-of-non-steroidal-anti-inflammatory-drugs-(nsaids)-in-patients-with-covi
Donc, en l’état de la #science le 19 avril et diffusé par l’#OMS, il n’existe aucune preuve d’une interraction négative entre l’#ibuprofène en particulier (#AINS) et le #coronavirus #covid_19.
At present there is no evidence of severe adverse events, acute health care utilization, long-term survival, or quality of life in patients with COVID-19, as a result of the use of NSAIDs.
